This stock is no longer traded. It was delisted on July 27, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
Inotiv Inc. is a prominent company specializing in contract research organization (CRO) services primarily aimed at enhancing drug discovery and development. The primary function of Inotiv is to provide comprehensive non-clinical and analytical services for pharmaceutical and biotechnology industries. These services play a critical role in the early stages of drug development, supporting the transition from discovery through clinical trials by ensuring safety and efficacy standards are met. Notably, Inotiv Inc. is involved in toxicology and pathology studies, bioanalysis, and consulting, all of which are crucial in advancing pharmaceutical research. The company’s significance in the market lies in its ability to streamline the drug development process for clients, potentially accelerating the timeline for bringing new therapies to market. Given the ever-evolving nature of medical research, Inotiv stands as a vital partner for clients seeking to navigate the complex regulatory environment while driving innovation in therapeutic solutions. Headquartered in the United States, Inotiv Inc. operates in one of the most dynamic sectors of the healthcare industry, supporting a global clientele with high-impact scientific expertise.
Website2701 Kent Avenue
West Lafayette, IN, 47906
United States
Summary of Jun 11's posts. Generated by AI.
Summary of Jun 10's posts. Generated by AI.
Summary of Nov 18's posts. Generated by AI.
Investors talking about NOTV also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.